--- title: 'Associate Director, Business Process Management & Operational Excellence at Vaxcyte' canonical: 'https://feeny.ai/job/associate-director-business-process-management-operational-excellence-vaxcyte-5p0t7q2tj3a5' type: 'job' last_seen: '2026-10-19' --- # Associate Director, Business Process Management & Operational Excellence at Vaxcyte - **Company:** Vaxcyte - **Location:** San Carlos, CA - **Posted:** 2026-10-15 - **Last confirmed live:** 2026-10-19 - **Apply:** https://boards.greenhouse.io/vaxcyte/jobs/5451724008?gh_jid=5451724008 ## Job description Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE:  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: This role within Technical Operations’ Capabilities & Business Operations function is critical for strengthening how Technical Operations translates strategy into executable work and builds repeatable, scalable ways of working as the organization advances toward commercialization and future growth. This role partners closely with Technical Operations leaders and cross-functional teams across Vaxcyte to shape strategic priorities into well-defined initiatives, strengthen end-to-end business processes and operating practices, and improve execution readiness through continuous improvement. The Principal also leads select high-priority cross-functional initiatives where additional coordination, specialized expertise, or execution capacity creates the greatest business value. The successful candidate brings a combination of business process management, operational excellence, strategy realization, and strong cross-functional execution capability. A core expectation of the role is that every initiative strengthens both business outcomes and organizational capability - building better processes, clearer governance, stronger ways of working, and reusable learning through the work itself. Essential Functions: Strategy Realization & Execution Readiness: - Partner with leaders to translate Technical Operations strategy and priorities into executable initiatives, with clear roadmaps, milestones, ownership, governance, decision rights, and measures of success. - Establish and apply project-shaping and execution-readiness practices so high-priority work is well defined, resourced, governed, and ready before execution begins. - Support demand intake and prioritization by helping leaders assess business value, readiness, dependencies, risk, resource implications, and sequencing. - Connect strategy, priorities, and execution by identifying gaps, interdependencies, and decisions needed to move work forward. Business Process Management & Operational Excellence: - Design, map, optimize, and sustain end-to-end business processes and cross-functional workflows that improve execution, scalability, and clarity across Technical Operations. - Establish practical process ownership, governance, operating rhythms, roles, decision rights, and performance measures where they create value. - Identify operational friction, duplication, bottlenecks, and handoff gaps, and simplify work across functional boundaries. - Lead continuous-improvement efforts using fit-for-purpose problem-solving and process-improvement methods, applying Lean/Six Sigma tools where useful without limiting the role to a single methodology. - Capture lessons learned, codify best practices, and build repeatable processes and playbooks that reduce dependence on individual effort or expertise. Cross-Functional Initiative Leadership: - Lead select high-priority cross-functional initiatives that call for neutral leadership, organizational coordination, specialized expertise, or added execution capacity. - Facilitate complex cross-functional decisions, working sessions, and problem-solving efforts that build alignment and accelerate action. - Strengthen the interfaces between Technical Operations and other functions so interdependent work stays integrated while functional ownership remains clear. - Build trusted relationships with leaders and technical experts, bringing an objective, business-minded perspective to execution challenges and tradeoffs. Organizational Capability: - Ensure major initiatives build organizational capability alongside near-term outcomes. - Help leaders establish sustainable ways of working that strengthen accountability, decision-making, coordination, and operational performance. - Partner with the Principal, Business Operations & Digital Enablement so business processes, portfolio visibility, data, systems, and digital solutions reinforce one another. Requirements: - Bachelor’s degree in Business, Operations, Engineering, Life Sciences, Organizational Development, or a related discipline; advanced degree preferred. - 10+ years of progressive experience in business process management, operational excellence, strategy execution, transformation, business operations, program leadership, or related disciplines. - Experience in biotechnology, pharmaceutical, biopharmaceutical manufacturing, Technical Operations, or another complex regulated environment strongly preferred. - Demonstrated experience designing and improving end-to-end business processes, including process architecture, process ownership, process mapping/redesign, governance, and performance management. - Demonstrated ability to translate broad strategy into executable plans and lead complex cross-functional initiatives from ambiguity through execution. - Strong understanding of operating models, governance, decision rights, continuous improvement, and organizational change and adoption. - Exceptional facilitation, communication, problem-solving, and executive presentation skills, with the ability to influence without direct authority. - Ability to operate effectively in a fast-paced, evolving environment and move comfortably between strategic thinking and hands-on execution. - Other combinations of education and/or experience may be considered. Reports to: Executive Director, Commercialization Capabilities & Strategic Projects Location: San Carlos, CA Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy): Hybrid (minimum of 3 days per week onsite) Compensation: The compensation package will be competitive and includes comprehensive benefits and an equity component. Salary Range: $170,000 - $200,000 (SF Bay Area). Salary ranges for non-California locations may vary. Relocation: This role is not eligible for relocation assistance. ## Equal Opportunity We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status. Recruitment Fraud Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at [vaxcyte.com/careers](https://vaxcyte.com/careers/). ## About Vaxcyte ## Company Overview - **One-liner**: Vaxcyte is a clinical-stage biotechnology company re-engineering how vaccines are made to eliminate bacterial infections, using a cell-free protein synthesis platform to develop high-fidelity, broad-spectrum vaccines. - **Entity Type**: Public (Ticker: PCVX) - **Headquarters**: San Carlos, California, United States - **Founded**: 2013 (as SutroVax; rebranded to Vaxcyte in 2020) - **Founders**: Not publicly available (the company emerged from Sutro Biopharma’s spin-out) ## Core Business - **Primary industry**: Biotechnology / Vaccines (Infectious Disease) - **Target customers**: Global healthcare systems, public health organizations, and ultimately patients (B2B/Institutional); the company develops vaccines for both pediatric and adult populations. - **Mission or purpose**: To protect humankind from the consequences of bacterial infections, eliminating diseases like invasive pneumococcal disease, Group A Strep, and Shigella. ## Products & Services - **VAX-31 (31-valent PCV)**: A broad-spectrum pneumococcal conjugate vaccine candidate in Phase 3 for adults and Phase 2 for infants. Designed to cover over 95% of circulating IPD serotypes in U.S. adults 50+ and ~94% in infants. FDA Breakthrough Therapy designation granted. - **VAX-24 (24-valent PCV)**: A pneumococcal conjugate vaccine candidate in Phase 2 for infants, designed to cover more serotypes than any infant PCV on the market today. - **VAX-A1 (Group A Strep)**: A preclinical conjugate vaccine candidate for Group A Strep, a disease with no currently approved vaccine. Phase 1 first-in-human study (adults) underway in Australia. - **VAX-GI (Shigella)**: A novel preclinical vaccine candidate targeting Shigella, a leading cause of diarrheal disease. - **Platform Technology**: A proprietary cell-free protein synthesis platform that enables site-specific, carrier-sparing conjugation to produce precisely targeted vaccines with enhanced immunogenicity. ## Market Standing - **Valuation/Market Cap**: ~$16.7 billion (as of early July 2026) - **Key Metric**: Total funding raised (private) is not applicable; as a public company, key metrics include cash position (~$2.0 billion as of Q1 2026) and R&D investment. The company is pre-revenue. - **Notable Investors/Partners**: Major institutional investors include Baker Bros. Advisors, Fidelity, and funds managed by BlackRock. Key partnership: exclusive license agreement with Sutro Biopharma for its cell-free protein synthesis platform. - **Growth Signals**: - Up to $1 billion commitment to expanding U.S. manufacturing with a new facility in North Carolina. - VAX-31 Phase 3 program (OPUS-1, OPUS-2, OPUS-3) topline data expected Q4 2026 – H1 2027. - Headcount growth: actively hiring across 100+ roles (Analytical, Commercial, Clinical, Conjugation, Quality, Regulatory). - Recognized as a Great Place to Work and Best Workplace in BioPharma (multiple years). ## Competitive Advantages - **Broadest-spectrum PCV candidates**: VAX-31 is the broadest-spectrum pneumococcal conjugate vaccine in the clinic, targeting up to 31 serotypes. - **Differentiated platform**: Cell-free protein synthesis allows for the creation of complex, high-fidelity vaccines that can overcome bacterial defense mechanisms (e.g., capsule-switching) that limit conventional cell-based vaccines. - **Carrier-sparing technology**: Site-specific conjugation enables a higher valency (more serotypes) without compromising immunogenicity or tolerability. - **Manufacturing scale**: Significant investment in U.S.-based production capacity provides a long-term supply chain advantage and aligns with "Investing in America" initiatives. ## Strategic Focus - **Primary**: Advance VAX-31 and VAX-24 through late-stage clinical trials to secure regulatory approval and establish a new standard of care for pneumococcal disease. - **Pipeline expansion**: Advance VAX-A1 (Group A Strep) and VAX-GI (Shigella) candidates through early clinical development. - **Manufacturing**: Scale up internal manufacturing capabilities to support commercial launch and global supply. - **Commercial readiness**: Building a commercial organization (e.g., hiring a VP of U.S. Market Access & Pricing, Senior Director of Product Launch) to prepare for potential VAX-31 launch. ## Why Work Here - **Culture**: Described as a "kindness-first" mindset with a focus on audacious goals, collaboration, and mutual support. Recognized as a *Great Place to Work* and *Best Workplace in BioPharma* (Fortune). - **Work Model**: Hybrid, Remote, and Onsite options available depending on role. San Carlos HQ offers a hybrid schedule. - **Total Rewards**: 100% paid health, dental, and vision insurance; 401k matching; flexible PTO and holidays; paid parental and sick leave; equity awards (stock options & RSUs); Employee Stock Purchase Plan; lifestyle spending account; mental health and wellness resources. - **Growth & Development**: Strong emphasis on learning culture, professional advancement through coaching, and career development programs. - **Mission-driven**: Employees are directly contributing to creating vaccines that protect every child born and every adult at risk from bacterial infections globally. ## Sources 1. [vaxcyte.com](https://vaxcyte.com/) 2. [vaxcyte.com/careers](https://vaxcyte.com/careers/) 3. [vaxcyte.com/job-listings](https://vaxcyte.com/job-listings/) 4. [vaxcyte.com/culture](https://vaxcyte.com/culture/) 5. [vaxcyte.com/pipeline](https://vaxcyte.com/pipeline/) ## Other roles at Vaxcyte - [Manager, Inventory and Operations Accounting](https://feeny.ai/job/manager-inventory-and-operations-accounting-vaxcyte-san-carlos-r66rjpkp6y1a) — San Carlos, CA - [Senior Accountant](https://feeny.ai/job/senior-accountant-vaxcyte-san-carlos-j4sqgfxb13nj) — San Carlos, CA - [Scientist II (Contract), Analytical Development](https://feeny.ai/job/scientist-ii-contract-analytical-development-vaxcyte-san-carlos-zpsadm0x2qst) — San Carlos, CA - [Systems Engineer](https://feeny.ai/job/systems-engineer-vaxcyte-san-carlos-zy2wf03ynbzs) — San Carlos, CA - [Senior Associate Scientist, Research](https://feeny.ai/job/senior-associate-scientist-research-vaxcyte-san-carlos-908rwbsfgzv7) — San Carlos, CA - [Associate Scientist II, Research](https://feeny.ai/job/associate-scientist-ii-research-vaxcyte-san-carlos-5ytv9687sh0g) — San Carlos, CA - [IT Operations Engineer](https://feeny.ai/job/it-operations-engineer-vaxcyte-san-carlos-y9kstk4b8rz9) — San Carlos, CA - [Manager, Facilities Engineering](https://feeny.ai/job/manager-facilities-engineering-vaxcyte-san-carlos-9z48ebpsa6x8) — San Carlos, CA - [Associate Scientist I, Research](https://feeny.ai/job/associate-scientist-i-research-vaxcyte-san-carlos-k9qmt16gbeaw) — San Carlos, CA - [Scientist I, Drug Product Analytics (Laboratory Automation)](https://feeny.ai/job/scientist-i-drug-product-analytics-laboratory-automation-vaxcyte-san-carlos-a3rh8631rv3k) — San Carlos, CA